1. Home
  2. CAE vs PCVX Comparison

CAE vs PCVX Comparison

Compare CAE & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAE Inc.

CAE

CAE Inc.

HOLD

Current Price

$24.41

Market Cap

8.2B

Sector

N/A

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$61.16

Market Cap

7.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAE
PCVX
Founded
1947
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
7.0B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
CAE
PCVX
Price
$24.41
$61.16
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$33.33
$88.25
AVG Volume (30 Days)
668.4K
931.6K
Earning Date
05-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.97
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$35.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.76
$30.81
52 Week High
$34.24
$65.00

Technical Indicators

Market Signals
Indicator
CAE
PCVX
Relative Strength Index (RSI) 41.69 55.01
Support Level $22.76 $52.18
Resistance Level $26.41 $63.52
Average True Range (ATR) 0.66 2.28
MACD -0.21 -0.17
Stochastic Oscillator 25.19 52.24

Price Performance

Historical Comparison
CAE
PCVX

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: i) Civil Aviation: Provides comprehensive training solutions for flight, cabin, maintenance, ground personnel and air traffic controllers in commercial, business and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training and crew sourcing services, as well as airline operations digital solutions; and ii) Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: